Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.44 USD | -1.97% |
|
+1.02% | -18.72% |
17/06 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
17/06 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.72% | 614M | |
+16.24% | 122B | |
+17.37% | 114B | |
+19.62% | 25.71B | |
-25.87% | 19.02B | |
-20.21% | 15.83B | |
-19.83% | 15.32B | |
-47.37% | 14.88B | |
+59.95% | 14.82B | |
+4.74% | 14.1B |
- Stock Market
- Equities
- ZYME Stock
- News Zymeworks Inc.
- Transcript : Zymeworks Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 12